| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0004 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.61 | 0.0004 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.57 | 0.001 |